Across TCGA pan-cancer cohorts, LINC00634 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LINC00634 data layer compared with 24 for mass-spec protein.
The strongest signal is observed in mesothelioma (MESO), where higher LINC00634 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00634 expression acts as an unfavorable survival marker.
MESO and UCEC are the cancer types where LINC00634 Mutation most reproducibly stratifies survival.